Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
NCT Number: NCT05300165
Beneficial effects of moderate chronic consumption of beer have been extensively reported, however, the mechanisms have not been elucidated yet. Gut microbiota is an important mediator in the homeostasis of the host. Polyphenols act as bacterial substrates and modulators of the gut microbiota. Indeed, the investigators have previously observed that the chronic moderate consumption of red wine by metabolic syndrome patients triggered in an amelioration of the metabolic syndrome variables, and this effect was mediated, at least partially, by the interaction of the gut microbiota with the polyphenols of the red wine. In this manner, beer has a medium content of polyphenols. Thus, the investigators propose that the beneficial effects of moderate chronic consumption of beer could be because of the action of the gut microbiota with the beer polyphenols. The investigators are going to perform an intervention study in which normal volunteers will consume three different beer types with different content in polyphenols and it will be analyzed the gut microbiota profile (Metagenomics), metabolites (Metabolomics) and metabolic syndrome markers (gene expression, ELISA) to establish the correspondent relationships, trying to decipher the implication of the gut microbiota in the beneficial effects of moderate chronic consumption of beer.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Málaga, 29010, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A daily beer will be consumed by the participants during a total of 6 weeks, changing every 2 weeks from alcohol-free lager beer, lager beer and dark beer
Time frame: Baseline, 2nd, 4th and 6th weeks visits
change from baseline in 16S rRNA amplicons determined in DNA from feces after 6 weeks
Time frame: Baseline and 6th weeks visits
change from baseline in the number of caloric consumption measured by an structured nutrient intake
Time frame: Baseline and 6th weeks visits
Change from baseline in waist circumference (cm) after the completion of the trial
Time frame: Baseline and 6th weeks visits
Change from baseline in serum glucose level after the completion of the trial
Time frame: Baseline and 6th weeks visits
Change from baseline in serum HDL-cholesterol level after the completion of the trial
Time frame: Baseline and 6th weeks visits
Change from baseline in serum triglycerides level after the completion of the trial
Time frame: Baseline and 6th weeks visits
Change from baseline in blood pressure (systolic and diastolic) after the completion of the trial
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Other
Acronym: BEEROTA18
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06608784
Brain Diseases, Central Nervous System Diseases
Sari, Mazandaran, Iran
View Trial DetailsNCT01298349
Mental Disorders, Normal Population
Afula, Israel
View Trial DetailsNCT01067482
Eye Diseases, Glaucoma
Hat Yai, Songkhla, Thailand., Thailand
View Trial DetailsNCT06893692
Normal Population
Lahore, Punjab Province, Pakistan
View Trial Details